Swine Flu Test Submitted to the FDA

By admin | May 14, 2009

Osmetech (LSE:OMH) has submitted a request to the US FDA for Emergency Use Authorization (EUA) for its Respiratory Pathogen Test Panel test to be used to screen for the swine flu virus. Osmetech’s Respiratory Pathogen Test Panel test, which is expected to be launched as a research use only (RUO) product next quarter, detects and [...]

FDA Approves New Influenza Vaccine Production Facility

By admin | May 6, 2009

The U.S. Food and Drug Administration (FDA) today announced that it has approved a new manufacturing facility used to produce influenza virus vaccines. The facility is approved for seasonal influenza vaccine production and could be used for the production of vaccine against the new 2009 H1N1 influenza strain.
As part of its overall pandemic influenza [...]

Multi-Faceted H1N1 Influenza Diagnostic Systems

By admin | May 6, 2009

Evogen, Inc., a molecular diagnostics company, is developing multi-faceted capabilities to address the air-monitoring, detection and diagnosis of Influenza A H1N1, or Swine Flu, in addition to several prevalent flu types.
Evogen’s molecular PCR diagnostic test is capable of rapidly and specifically detecting H1N1 pandemic Influenza, utilizing HyBeacons® technology. The test can be implemented on PCR [...]

© 2007 Vaccine Market, - WordPress Themes by DBT